Keyphrases
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
89%
COVID-19
85%
Receptor-binding Domain
67%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
66%
Coronavirus Infections
45%
Severe Acute Respiratory Syndrome
42%
Spike Protein
41%
Neutralizing Antibodies
36%
Angiotensin-converting Enzyme 2 (ACE2)
35%
Transgenic Mice
32%
SARS-CoV-2 Infection
31%
Middle East Respiratory Syndrome
31%
Lung
31%
Virus
25%
Interleukin-2
23%
Coronavirus
23%
Coronavirus Disease (COVID)
22%
Subunit Vaccine
21%
Coronavirus Vaccine
20%
Dipeptidyl peptidase-4 (DPP-4)
19%
B Cells
19%
Vaccine Candidate
18%
Immunization
18%
T Cells
18%
Virus Infection
17%
Mouse Model
16%
Recombinant Receptors
14%
CD81
14%
Cathepsin L
13%
Severe Acute Respiratory Syndrome-associated Coronavirus
13%
Hepatitis C Virus
13%
B Cell Activation
13%
Monoclonal Antibody
13%
Interferon-α (IFN-α)
13%
Antiviral Activity
12%
Therapeutic Efficacy
11%
Human Antibody
11%
Coronavirus Spike Protein
11%
Immunopathology
10%
Immunogenicity
10%
Domain-independent
10%
Viral Infection
9%
Innate Immune Response
9%
Host Gene Expression
9%
Post-infection
9%
Superinfection
9%
Fusion Inhibitor
9%
Cellular Factors
9%
Nanoluciferase
9%
Truncated Receptor
9%
Immunology and Microbiology
Middle East Respiratory Syndrome Coronavirus
83%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
SARS Coronavirus
59%
Receptor Binding
54%
Severe Acute Respiratory Syndrome
48%
Transgenic Mouse
45%
Spike
42%
Neutralizing Antibody
32%
T Cell
30%
interferon
28%
Interleukin 2
26%
Viral Disease
25%
Coronavirinae
25%
Mouse Model
23%
Middle East Respiratory Syndrome
22%
Leporidae
21%
Innate Immune System
20%
Subunit Vaccine
19%
COVID-19
18%
B Cell
18%
Dipeptidyl Peptidase IV
17%
Immunology
17%
CD81
14%
Immunopathology
14%
Hepatitis C Virus
13%
B Cell Activation
13%
Gene Expression
12%
Adjuvant
12%
Epitope
11%
Immune Response
11%
Neutralization
11%
Antigen
11%
Monoclonal Antibody
11%
Immunogenicity
10%
Viral Load
10%
Human Immunodeficiency Virus 1
9%
T Cell Receptor
9%
Bacteriophage
9%
Superinfection
9%
Cell Line
9%
Junin Virus
9%
Adenoviridae
9%
B Lymphocyte Growth Factor
9%
Viral Envelope
9%
Influenza
9%
Cell Function
9%
Natural Killer Cell
9%
Rift Valley Fever Virus
9%
Human Immunodeficiency Virus
8%
Cytokine
8%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Infection
72%
Middle East Respiratory Syndrome Coronavirus
52%
Receptor
51%
Middle East Respiratory Syndrome
44%
Coronavirinae
39%
Severe Acute Respiratory Syndrome
38%
Disease
31%
Transgenic Mouse
31%
Neutralizing Antibody
22%
Proteinase
19%
Dipeptidyl Peptidase IV
18%
Proteinase Inhibitor
18%
Mouse Model
16%
Immunopathology
15%
Cathepsin L
13%
Nanoparticle
13%
Cysteine Proteinase
12%
Angiotensin Converting Enzyme 2
11%
Interferon
10%
Recombinant Receptor
10%
Antiviral Activity
10%
Antivirus Agent
10%
Monoclonal Antibody
9%
Virus Infection
9%
Antiporter
9%
Argentine Hemorrhagic Fever
9%
Chimeric Protein
9%
Vitronectin
8%
Inflammation
7%
Adjuvant
7%
Recombinant Protein
7%
Interferon Type I
7%
Cytokine
7%
IC50
7%
Cruzipain
7%
Junin Virus
6%
Interleukin 2
6%
Severe Acute Respiratory Syndrome Vaccine
6%
Infectious Agent
5%
Hepatitis C Virus
5%
Antigen
5%
Diseases
5%
Human Immunodeficiency Virus Fusion Inhibitor
5%
Papain
5%
Syndrome
5%